Clinical trials
Not yet recruiting Phase 2 Lung Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 11 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Convalife (Shanghai) Co., Ltd. | 2 |
| Shanghai Chest Hospital | 2 |
| Shanghai Pulmonary Hospital, Shanghai, China | 2 |
| Sichuan University | 2 |
| Sun Yat-sen University | 2 |
| The First Affiliated Hospital of Guangzhou Medical University | 2 |
| Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 1 |
| Anusha Chidharla, MD | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Chinese University of Hong Kong | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 48 |
| Carcinoma, Non-Small-Cell Lung | 22 |
| Breast Neoplasms | 4 |
| Melanoma | 3 |
| Stomach Neoplasms | 3 |
| Adenocarcinoma of Lung | 2 |
| Carcinoma, Transitional Cell | 2 |
| Colorectal Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.